Hidde L Ploegh Selected Research

Hidde L Ploegh Research Topics

Disease

35	Neoplasms (Cancer) 01/2021 - 10/2002
27	Infections 01/2021 - 06/2006
8	Human Influenza (Influenza) 01/2017 - 11/2009
7	Virus Diseases (Viral Diseases) 01/2022 - 02/2004
6	Melanoma (Melanoma, Malignant) 10/2020 - 08/2013
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021 - 08/2005
4	Neoplasm Metastasis (Metastasis) 11/2019 - 03/2011
4	Inflammation (Inflammations) 01/2014 - 11/2002
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2021 - 07/2013
3	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 11/2008
3	Multiple Myeloma 03/2006 - 05/2005
2	Rheumatoid Arthritis 11/2021 - 07/2013
2	Vesicular Stomatitis 01/2017 - 01/2016
2	Toxoplasmosis 11/2016 - 03/2010
2	Dystonia musculorum deformans type 1 01/2016 - 08/2014
2	Dystonic Disorders (Writer's Cramp) 01/2016 - 08/2014
2	Colitis 01/2015 - 01/2014
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022
1	Obesity 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Adenocarcinoma 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2017
1	Experimental Melanoma 08/2017
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2017
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2017
1	Central Nervous System Diseases (CNS Diseases) 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Opportunistic Infections (Opportunistic Infection) 01/2017
1	Anemia 12/2016

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2006
10	AntigensIBA 01/2022 - 12/2008
10	Peptides (Polypeptides)IBA 10/2020 - 08/2005
9	Single-Domain AntibodiesIBA 11/2021 - 12/2016
8	AntibodiesIBA 01/2021 - 11/2008
6	CytokinesIBA 01/2020 - 03/2010
5	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2012
5	EpitopesIBA 01/2022 - 12/2008
4	LigandsIBA 01/2022 - 02/2013
4	AutoantigensIBA 11/2021 - 07/2013
4	UbiquitinIBA 12/2016 - 03/2004
4	Ubiquitin-Specific ProteasesIBA 02/2013 - 11/2005
4	Peptide Hydrolases (Proteases)FDA Link 10/2009 - 10/2002
3	VaccinesIBA 01/2020 - 11/2008
3	Biological ProductsIBA 01/2017 - 08/2008
3	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 03/2013
3	Deubiquitinating EnzymesIBA 02/2015 - 07/2006
3	Interleukin-12 (IL 12)IBA 07/2013 - 03/2010
3	CathepsinsIBA 08/2008 - 06/2002
3	Bortezomib (Velcade)FDA Link 03/2006 - 05/2005
2	Chimeric Antigen ReceptorsIBA 01/2020 - 02/2015
2	TetraspaninsIBA 11/2019 - 03/2011
2	Blocking AntibodiesIBA 01/2019 - 08/2017
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2016
2	Viral AntigensIBA 01/2017 - 12/2008
2	AutoantibodiesIBA 01/2017 - 01/2012
2	B7-H1 AntigenIBA 01/2017 - 05/2016
2	Monoclonal AntibodiesIBA 05/2016 - 02/2016
2	Pharmaceutical PreparationsIBA 02/2016 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 01/2016 - 08/2014
2	Diphtheria ToxinIBA 10/2014 - 11/2009
2	LipidsIBA 04/2013 - 06/2012
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2008 - 03/2008
2	Cathepsin BIBA 08/2008 - 06/2002
2	Proteasome InhibitorsIBA 03/2006 - 05/2005
2	DipeptidesIBA 03/2006 - 05/2005
2	Boronic AcidsIBA 03/2006 - 05/2005
2	EnzymesIBA 03/2004 - 11/2002
1	Pattern Recognition ReceptorsIBA 01/2022
1	MannansIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	GlucocorticoidsIBA 11/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021
1	4-O-carboxymethylascochlorinIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	PCSK9 InhibitorsIBA 01/2021
1	Glycophorins (Glycophorin C)IBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	LDL CholesterolIBA 01/2021
1	SolutionsIBA 01/2021
1	SubtilisinIBA 01/2021
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	Galectin 3 (LGALS3)IBA 11/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	Cancer VaccinesIBA 01/2018
1	CarbohydratesIBA 08/2017
1	Complement System Proteins (Complement)IBA 08/2017
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2017
1	NucleoproteinsIBA 01/2017
1	Influenza A virus NP proteinIBA 12/2016
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2016
1	MetalsIBA 12/2016
1	Arginine (L-Arginine)FDA Link 12/2016

Therapy/Procedure

14	Therapeutics 01/2021 - 09/2005
7	Immunotherapy 11/2019 - 01/2015